ITMI991299A0 - Uso di anticorpi contro antigeni di superficie per il trattamento dell a malattia trapianto contro ospite - Google Patents

Uso di anticorpi contro antigeni di superficie per il trattamento dell a malattia trapianto contro ospite

Info

Publication number
ITMI991299A0
ITMI991299A0 IT99MI001299A ITMI991299A ITMI991299A0 IT MI991299 A0 ITMI991299 A0 IT MI991299A0 IT 99MI001299 A IT99MI001299 A IT 99MI001299A IT MI991299 A ITMI991299 A IT MI991299A IT MI991299 A0 ITMI991299 A0 IT MI991299A0
Authority
IT
Italy
Prior art keywords
graft
versus
treatment
antibody against
host disease
Prior art date
Application number
IT99MI001299A
Other languages
English (en)
Inventor
Josee Golay
Martino Introna
Alessandro Rambaldi
Andrea Biondi
Original Assignee
Consiglio Nazionale Ricerche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Consiglio Nazionale Ricerche filed Critical Consiglio Nazionale Ricerche
Priority to IT1999MI001299A priority Critical patent/ITMI991299A1/it
Publication of ITMI991299A0 publication Critical patent/ITMI991299A0/it
Priority to ES00940332T priority patent/ES2278616T3/es
Priority to DE60033030T priority patent/DE60033030T2/de
Priority to JP2001502875A priority patent/JP2003501482A/ja
Priority to CNB008088330A priority patent/CN1253208C/zh
Priority to SI200030932T priority patent/SI1185299T1/sl
Priority to PL00352860A priority patent/PL352860A1/xx
Priority to HU0201600A priority patent/HUP0201600A3/hu
Priority to AU55303/00A priority patent/AU774206B2/en
Priority to NZ515992A priority patent/NZ515992A/xx
Priority to EP00940332A priority patent/EP1185299B1/en
Priority to IL14693400A priority patent/IL146934A0/xx
Priority to CZ20014450A priority patent/CZ20014450A3/cs
Priority to EEP200100667A priority patent/EE200100667A/xx
Priority to TR2001/03581T priority patent/TR200103581T2/xx
Priority to KR1020017015954A priority patent/KR20020026455A/ko
Priority to PT00940332T priority patent/PT1185299E/pt
Priority to CA002376288A priority patent/CA2376288A1/en
Priority to PCT/EP2000/005212 priority patent/WO2000076542A1/en
Priority to DK00940332T priority patent/DK1185299T3/da
Priority to SK1813-2001A priority patent/SK18132001A3/sk
Publication of ITMI991299A1 publication Critical patent/ITMI991299A1/it
Priority to ZA200110004A priority patent/ZA200110004B/xx
Priority to BG106193A priority patent/BG106193A/bg
Priority to IS6195A priority patent/IS6195A/is
Priority to NO20016035A priority patent/NO20016035L/no
Priority to HK02105388.7A priority patent/HK1043549B/zh
Priority to US11/498,103 priority patent/US20070014785A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2887—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against CD20
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K2035/124—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells the cells being hematopoietic, bone marrow derived or blood cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Transplantation (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
IT1999MI001299A 1999-06-11 1999-06-11 Uso di anticorpi contro antigeni di superficie per il trattamento della malattia trapianto contro ospite ITMI991299A1 (it)

Priority Applications (27)

Application Number Priority Date Filing Date Title
IT1999MI001299A ITMI991299A1 (it) 1999-06-11 1999-06-11 Uso di anticorpi contro antigeni di superficie per il trattamento della malattia trapianto contro ospite
SK1813-2001A SK18132001A3 (sk) 1999-06-11 2000-06-07 Použitie protilátky proti antigénom
CZ20014450A CZ20014450A3 (cs) 1999-06-11 2000-06-07 Farmaceutický prostředek
TR2001/03581T TR200103581T2 (tr) 1999-06-11 2000-06-07 Graft versus host hastalığı tedavisinde CD20' ye karşı antikorların kullanımı.
JP2001502875A JP2003501482A (ja) 1999-06-11 2000-06-07 移植片対宿主疾患の処置のためのｃｄ２０に対する抗体の使用
CNB008088330A CN1253208C (zh) 1999-06-11 2000-06-07 利用抗cd20抗体治疗移植物抗宿主疾病
SI200030932T SI1185299T1 (sl) 1999-06-11 2000-06-07 Uporaba protiteles proti cd20 za zdravljenje reakcije presadka proti gostitelju
PL00352860A PL352860A1 (en) 1999-06-11 2000-06-07 Use of antibodies against cd20 for the treatment of the graft versus host disease
HU0201600A HUP0201600A3 (en) 1999-06-11 2000-06-07 Use of antibodies against cd20 for the treatment of the graft versus host disease
AU55303/00A AU774206B2 (en) 1999-06-11 2000-06-07 Use of antibodies against CD20 for the treatment of the graft versus host disease
NZ515992A NZ515992A (en) 1999-06-11 2000-06-07 Use of antibodies against CD20 for the treatment of the graft versus host disease
EP00940332A EP1185299B1 (en) 1999-06-11 2000-06-07 Use of antibodies against cd20 for the treatment of the graft versus host disease
IL14693400A IL146934A0 (en) 1999-06-11 2000-06-07 Use of antibodies afainst cd20 for the treatment of the graft versus host disease
ES00940332T ES2278616T3 (es) 1999-06-11 2000-06-07 Uso de anticuerpos contra cd20 para el tratamiento de la enfermedad de injerto contra huesped.
EEP200100667A EE200100667A (et) 1999-06-11 2000-06-07 CD20 vastaste antikehade kasutamine transplantaadi peremehevastase reaktsiooni raviks
DE60033030T DE60033030T2 (de) 1999-06-11 2000-06-07 Verwendung von gegen cd20 gerichteten antikörpern zur behandlung der graft-versus-host-krankheit
KR1020017015954A KR20020026455A (ko) 1999-06-11 2000-06-07 이식편 대 숙주반응질환의 치료를 위한 씨디20에 대한 항체
PT00940332T PT1185299E (pt) 1999-06-11 2000-06-07 Utilização de anticorpos contra cd20 para o tratamento da doença enxerto versus hospedeiro
CA002376288A CA2376288A1 (en) 1999-06-11 2000-06-07 Use of antibodies against cd20 for the treatment of the graft versus host disease
PCT/EP2000/005212 WO2000076542A1 (en) 1999-06-11 2000-06-07 Use of antibodies against cd20 for the treatment of the graft versus host disease
DK00940332T DK1185299T3 (da) 1999-06-11 2000-06-07 Anvendelse af antistoffer mod CD20 til behandling af graft versus host disease
ZA200110004A ZA200110004B (en) 1999-06-11 2001-12-05 Use of antibodies against CD20 for the treatment of the graft versus host disease.
BG106193A BG106193A (bg) 1999-06-11 2001-12-07 Използване на антитела срещу cd20 за лечение на заболявания при трансплантации
IS6195A IS6195A (is) 1999-06-11 2001-12-10 Notkun á mótefnum gegn CD20 til meðhöndlunar á þegahöfnunarveiki
NO20016035A NO20016035L (no) 1999-06-11 2001-12-10 Anvendelse av antistoff mot CD20 ved behandling av avstötning av implantanter
HK02105388.7A HK1043549B (zh) 1999-06-11 2002-07-22 利用抗cd20抗體治療移植物抗宿主疾病
US11/498,103 US20070014785A1 (en) 1999-06-11 2006-08-03 Use of antibodies against CD20 for the treatment of the graft versus host disease

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT1999MI001299A ITMI991299A1 (it) 1999-06-11 1999-06-11 Uso di anticorpi contro antigeni di superficie per il trattamento della malattia trapianto contro ospite

Publications (2)

Publication Number Publication Date
ITMI991299A0 true ITMI991299A0 (it) 1999-06-11
ITMI991299A1 ITMI991299A1 (it) 2000-12-11

Family

ID=11383150

Family Applications (1)

Application Number Title Priority Date Filing Date
IT1999MI001299A ITMI991299A1 (it) 1999-06-11 1999-06-11 Uso di anticorpi contro antigeni di superficie per il trattamento della malattia trapianto contro ospite

Country Status (26)

Country Link
US (1) US20070014785A1 (it)
EP (1) EP1185299B1 (it)
JP (1) JP2003501482A (it)
KR (1) KR20020026455A (it)
CN (1) CN1253208C (it)
AU (1) AU774206B2 (it)
BG (1) BG106193A (it)
CA (1) CA2376288A1 (it)
CZ (1) CZ20014450A3 (it)
DE (1) DE60033030T2 (it)
DK (1) DK1185299T3 (it)
EE (1) EE200100667A (it)
ES (1) ES2278616T3 (it)
HK (1) HK1043549B (it)
HU (1) HUP0201600A3 (it)
IL (1) IL146934A0 (it)
IS (1) IS6195A (it)
IT (1) ITMI991299A1 (it)
NO (1) NO20016035L (it)
NZ (1) NZ515992A (it)
PL (1) PL352860A1 (it)
PT (1) PT1185299E (it)
SK (1) SK18132001A3 (it)
TR (1) TR200103581T2 (it)
WO (1) WO2000076542A1 (it)
ZA (1) ZA200110004B (it)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1637160A3 (en) 1999-05-07 2006-05-03 Genentech, Inc. Treatment of autoimmune diseases with antagonists which bind to B cell surface markers
US7754208B2 (en) 2001-01-17 2010-07-13 Trubion Pharmaceuticals, Inc. Binding domain-immunoglobulin fusion proteins
US20030133939A1 (en) 2001-01-17 2003-07-17 Genecraft, Inc. Binding domain-immunoglobulin fusion proteins
BRPI0316779B1 (pt) * 2002-12-16 2020-04-28 Genentech Inc anticorpo humanizado que liga cd20 humano, composição, artigo manufaturado, método de indução da apoptose, método de tratamento de câncer cd20 positivo, métodos de tratamento de doenças autoimunes, ácidos nucléicos isolados, vetores de expressão, células hospedeiras, método para a produção de um anticorpo 2h7 humanizado, polipeptídeo isolado, formulação líquida, método de tratamento de artrite reumatóide (ra) e anticorpos de ligação de cd20 humanizados
CN1316019C (zh) * 2002-12-26 2007-05-16 中国医学科学院中国协和医科大学血液学研究所血液病医院 抗cd20嵌合抗体突变体基因及其应用
ES2322267T3 (es) 2003-04-09 2009-06-18 Genentech, Inc. Terapia de una enfermedad autoinmunologica en un paciente que presenta una respuesta inadecuada a un inhibidor de tnf-alfa.
KR101412271B1 (ko) 2003-05-09 2014-06-25 듀크 유니버시티 Ｃｄ２０-특이적 항체 및 이를 이용한 방법
KR20060027801A (ko) 2003-06-05 2006-03-28 제넨테크, 인크. Ｂ 세포 장애에 대한 조합 요법
EP1730288B1 (en) * 2004-03-22 2013-05-15 The Ohio State University Research Foundation Methods for transfecting natural killer cells
KR20070029733A (ko) 2004-06-04 2007-03-14 제넨테크, 인크. 다발성 경화증의 치료 방법
KR100864549B1 (ko) 2004-08-04 2008-10-20 어플라이드 몰리큘라 에볼류션, 인코포레이티드 변이체 ｆｃ 영역
CN101223448B (zh) 2005-05-20 2012-01-18 健泰科生物技术公司 来自自身免疫病受试者的生物学样品的预处理
AU2006272597A1 (en) 2005-07-25 2007-02-01 Emergent Product Development Seattle Llc Single dose use of CD20-specific binding molecules
UA97469C2 (uk) 2005-07-25 2012-02-27 Емерджент Продакт Дівелопмент Сіетл, Елелсі Гуманізована специфічна до cd37 зв'язувальна молекула імуноглобуліну
MY149159A (en) 2005-11-15 2013-07-31 Hoffmann La Roche Method for treating joint damage
AU2006318539B2 (en) 2005-11-23 2012-09-13 Genentech, Inc. Methods and compositions related to B cell assays
CN101008291B (zh) * 2006-01-26 2010-05-12 金海产品有限公司 用于水池清洁机的密封盒装置
NZ573646A (en) 2006-06-12 2012-04-27 Wyeth Llc Single-chain multivalent binding proteins with effector function
CA2584494A1 (en) * 2007-03-27 2008-09-27 Jeffrey A. Medin Vector encoding therapeutic polypeptide and safety elements to clear transduced cells
JP5403752B2 (ja) * 2007-06-22 2014-01-29 北海道公立大学法人 札幌医科大学 移植片対宿主疾患の検査および治療方法
LT3597659T (lt) 2007-07-09 2023-05-10 Genentech, Inc. Disulfidinės jungties redukcijos prevencijos būdas gaminant polipeptidą rekombinantiniu būdu
WO2009018411A1 (en) 2007-07-31 2009-02-05 Regeneron Pharmaceuticals, Inc. Human antibodies to human cd20 and method of using thereof
AU2008312406B2 (en) 2007-10-16 2014-03-06 Ares Trading S.A. Combination of BLyS inhibition and anti-CD 20 agents for treatment of autoimmune disease
EP2077281A1 (en) 2008-01-02 2009-07-08 Bergen Teknologioverforing AS Anti-CD20 antibodies or fragments thereof for the treatment of chronic fatigue syndrome
WO2009114942A1 (en) 2008-03-20 2009-09-24 University Health Network Thymidylate kinase fusions and uses thereof
NZ603059A (en) 2008-04-11 2014-07-25 Emergent Product Dev Seattle Cd37 immunotherapeutic and combination with bifunctional chemotherapeutic thereof
AR073295A1 (es) 2008-09-16 2010-10-28 Genentech Inc Metodos para tratar la esclerosis multiple progresiva. articulo de fabricacion.
WO2010075249A2 (en) 2008-12-22 2010-07-01 Genentech, Inc. A method for treating rheumatoid arthritis with b-cell antagonists
SG178358A1 (en) 2009-08-11 2012-03-29 Genentech Inc Production of proteins in glutamine-free cell culture media
EP2533810B1 (en) 2010-02-10 2016-10-12 ImmunoGen, Inc. Cd20 antibodies and uses thereof
JOP20200236A1 (ar) 2012-09-21 2017-06-16 Regeneron Pharma الأجسام المضادة لمضاد cd3 وجزيئات ربط الأنتيجين ثنائية التحديد التي تربط cd3 وcd20 واستخداماتها
TWI701042B (zh) 2014-03-19 2020-08-11 美商再生元醫藥公司 用於腫瘤治療之方法及抗體組成物
PL3221359T3 (pl) 2014-11-17 2020-11-16 Regeneron Pharmaceuticals, Inc. Sposoby leczenia nowotworów przy użyciu dwuswoistego przeciwciała CD3XCD20
PT3303373T (pt) 2015-05-30 2020-07-14 Molecular Templates Inc Estruturas de subunidade a de toxina shiga desimunizadas e moléculas de direcionamento celular compreendendo as mesmas
LT3313879T (lt) 2015-06-24 2022-03-25 F. Hoffmann-La Roche Ag Antikūnai prieš transferino receptorių su pritaikytu giminingumu
US11352426B2 (en) 2015-09-21 2022-06-07 Aptevo Research And Development Llc CD3 binding polypeptides
TWI819458B (zh) 2015-10-02 2023-10-21 瑞士商赫孚孟拉羅股份公司 雙特異性抗‐人類cd20/人類轉鐵蛋白受體抗體及使用方法
AR106189A1 (es) 2015-10-02 2017-12-20 Hoffmann La Roche ANTICUERPOS BIESPECÍFICOS CONTRA EL A-b HUMANO Y EL RECEPTOR DE TRANSFERRINA HUMANO Y MÉTODOS DE USO
EP4252629A3 (en) 2016-12-07 2023-12-27 Biora Therapeutics, Inc. Gastrointestinal tract detection methods, devices and systems
EP3600416B1 (en) 2017-03-30 2023-06-07 Biora Therapeutics, Inc. Treatment of a disease of the gastrointestinal tract with an immune modulatory agent released using an ingestible device
WO2019246312A1 (en) 2018-06-20 2019-12-26 Progenity, Inc. Treatment of a disease of the gastrointestinal tract with an immunomodulator
US20230009902A1 (en) 2018-06-20 2023-01-12 Progenity, Inc. Treatment of a disease or condition in a tissue orginating from the endoderm
CA3110513A1 (en) 2018-08-31 2020-03-05 Regeneron Pharmaceuticals, Inc. Dosing strategy that mitigates cytokine release syndrome for cd3/c20 bispecific antibodies
KR20210095165A (ko) 2018-11-19 2021-07-30 프로제너티, 인크. 바이오의약품으로 질환을 치료하기 위한 방법 및 디바이스
CN115666704A (zh) 2019-12-13 2023-01-31 比奥拉治疗股份有限公司 用于将治疗剂递送至胃肠道的可摄取装置

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5272082A (en) * 1992-03-30 1993-12-21 The Wistar Institute Of Anatomy & Biology Cytotoxic T-ALL cell lines and uses therefor
US5736137A (en) * 1992-11-13 1998-04-07 Idec Pharmaceuticals Corporation Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma
IL127211A0 (en) * 1996-05-31 1999-09-22 Genetic Therapy Inc Prevention of graft-versus-host disease with t-cells including polynucleotides encoding negative selective markers
GB9705744D0 (en) * 1997-03-20 1997-05-07 Davies Alison M Methods for selecting cells and their uses

Also Published As

Publication number Publication date
US20070014785A1 (en) 2007-01-18
CA2376288A1 (en) 2000-12-21
PT1185299E (pt) 2007-03-30
HK1043549A1 (en) 2002-09-20
DE60033030T2 (de) 2007-05-31
JP2003501482A (ja) 2003-01-14
HUP0201600A3 (en) 2005-04-28
DK1185299T3 (da) 2007-05-21
AU774206B2 (en) 2004-06-17
EP1185299A1 (en) 2002-03-13
IS6195A (is) 2001-12-10
CZ20014450A3 (cs) 2002-04-17
TR200103581T2 (tr) 2002-08-21
WO2000076542A1 (en) 2000-12-21
DE60033030D1 (de) 2007-03-08
HK1043549B (zh) 2006-09-01
AU5530300A (en) 2001-01-02
CN1355712A (zh) 2002-06-26
CN1253208C (zh) 2006-04-26
PL352860A1 (en) 2003-09-08
NO20016035L (no) 2002-02-11
NZ515992A (en) 2004-01-30
SK18132001A3 (sk) 2002-05-09
IL146934A0 (en) 2002-08-14
EP1185299B1 (en) 2007-01-17
EE200100667A (et) 2003-02-17
ES2278616T3 (es) 2007-08-16
NO20016035D0 (no) 2001-12-10
HUP0201600A2 (en) 2002-08-28
ITMI991299A1 (it) 2000-12-11
KR20020026455A (ko) 2002-04-10
BG106193A (bg) 2002-08-30
ZA200110004B (en) 2003-02-26

Similar Documents

Publication Publication Date Title
ITMI991299A0 (it) Uso di anticorpi contro antigeni di superficie per il trattamento dell a malattia trapianto contro ospite
NL300269I2 (nl) Werkwijze voor het vervaardigen van een humaan-papillomavirusvaccin
DK1228217T3 (da) Konserverede neisseria-antigener
IT1317741B1 (it) Metodo per la preparazione di 5-cianoftalide.
IT1319692B1 (it) Chiosco per la preparazione di razioni di pasta all'italiana.
NO20015227L (no) Fremgangsmate for a oke effektiviteten til anti-cancer midler
EE04234B1 (et) L-fenüülefriinvesinikkloriidi valmistamise meetod
IT1319251B1 (it) Metodo per la preparazione di 5-carbossiftalide.
IS6381A (is) Nýjung við notkun mótefna í bóluefni
ITRM20000341A0 (it) Composti utili per la preparazione di medicamenti ad attivita' inibitrice della fosfodiesterasi iv.
MA27184A1 (fr) Dosage d'anticorps anti-ingap
DE60016769D1 (de) Antagonisten des vitronectin-receptors
ITRM20030196A1 (it) Uso di reagenti per la preparazione di un medicamento
IT248147Y1 (it) Cassero perfezionato per la costruzione di pavimenti, solai o simili
IT1310979B1 (it) Metodo per fabbricare piastrelle aventi l'aspetto delle antichepiastrelle rustiche di fabbricazione artigianale.
ITRM20040288A1 (it) Uso della 7-t-butossiimminometilcamptotecina per la preparazione di un medicamento per il trattamento delle neoplasie dell'utero.
ITRE990116A0 (it) Metodo per fabbricare piastrelle aventi l'aspetto della pietra di cava spaccata.
FI4385U1 (fi) Metalliaihioinen betonitasolankku
ITGE20000016V0 (it) Dispositivo per la misurazione dell'inclinazione di superfici.
IT1307295B1 (it) Procedimento per la preparazione di filati ondee o compensina.
ITGE20000007A0 (it) Dispositivo ad azionamento centralizzato, per il movimento alternato di traslazione orizzontale e di sollevamento-abbassamento dell'elevare
IT1318330B1 (it) Procedimento per la formazione di elementi ceramici angolari confinitura superficiale uniforme.
IT1310022B1 (it) Rullo per via a rulli per il trasferimento di bramme calde o simili.
ITRM20010292A1 (it) Uso dell'acetil l-carnitina per la preparazione di un medicamento peril trattamento dell'anedonia.
ITMI20010641U1 (it) Dispositivo di supporto temporaneo di decorazioni, particolarmente per torte e simili